Related Experiment Video
Updated: Jun 4, 2025
09:57
Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
2.5K
Measuring the Burden of Epilepsy Hospitalizations in CDKL5 Deficiency Disorder
Mohammed Junaid1, Kingsley Wong1, Minna A Korolainen2
1The Kids Research Institute Australia, The University of Western Australia, Northern Entrance, Western Australia, Australia.
Pediatric Neurology
|December 20, 2024
Summary
Hospitalizations are common in CDKL5 Deficiency Disorder (CDD), particularly in infants and those requiring multiple antiseizure medications. Improved seizure management is crucial for reducing this burden.
Area of Science:
- Neurology
- Genetics
- Public Health
Background:
- CDKL5 Deficiency Disorder (CDD) is a rare epileptic encephalopathy with limited data on hospital service utilization.
- Understanding hospitalization patterns is vital for effective service planning for individuals with CDD.
Purpose of the Study:
- To investigate hospitalization rates and length of stay in a cohort of individuals with genetically verified CDD.
- To identify factors associated with hospital service use in this population.
Main Methods:
- Utilized baseline and longitudinal data from 379 individuals in the International CDKL5 Disorder Database.
- Analyzed hospitalization counts and length of stay for seizure- and non-seizure-related causes using negative binomial regression.
- Examined associations with gender, age, genetic variant, and antiseizure medication use.
Main Results:
- Observed 2880 hospitalizations, with two-thirds seizure-related.
- Infants experienced significantly higher hospitalization rates compared to older individuals.
- Higher antiseizure medication use correlated with increased seizure-related hospitalization rates.
Conclusions:
- Significant hospitalization burden exists in CDD, especially in preschool-aged children.
- There is an urgent need for enhanced seizure management strategies in CDD.
- The multiplicity of antiseizure medications used highlights challenges in treatment efficacy.
Keywords:
CDKL5 deficiency disorderDevelopmental and epileptic encephalopathyHospitalization burdenNonseizure hospitalizationsSeizure managementMore Related Videos
Related Concept Videos
01:24Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
01:13Seizures: Classification
300
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
300
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:20Inborn Errors of Metabolism
127
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
127